Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 508-512    DOI: 10.31083/j.ejgo.2020.04.5189
Systematic Review Previous articles | Next articles
Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis
Liman Yang1, *(), Jing Jin1, Juhong Liu1
1Department of Ultrasonic, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, P. R. China
Download:  PDF(169KB)  ( 254 ) Full text   ( 12 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: We aimed to determine whether a correlation exists between the polymorphisms of matrix metalloproteinases (MMPs) MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) and cervical cancer (CC). Methods: A literature search up to September 28, 2018, in PubMed, the Cochrane Library, and Embase was conducted. Odds ratio (OR) and 95% confidence interval (CI) were used as effect models. The quality, heterogeneity, and publication bias of the included studies were assessed. Results: Five studies with a total of 1,630 participants were included. For the G vs. A and GG vs. AA model of the rs11568818 gene, no significant heterogeneity was found (p < 0.05, I2 > 50%). No statistical significance was found for all the rs243865 models, indicating no significant association between rs243865 and CC. The meta-analysis of the rs11568818 gene polymorphism revealed a statistical significance for G vs. A (OR = 1.3719; 95% CI, 1.1480–1.6395; P = 0.0005), GG vs. AA (OR = 1.8561; 95% CI, 1.2682–2.7165; P = 0.0015), and GG vs. AA+GA (OR = 1.7448; 95% CI, 1.0104–3.0130; P = 0.0458). No publication bias was found for all the rs11568818 and rs243865 models, which suggested that the present results were reliable. Conclusions: MMP7-181A/G (rs11568818) was associated with CC; however, MMP2-C1306T (rs243865) was not associated with CC.
Key words:  Cervical cancer      Gene polymorphism      Matrix metalloproteinases      Meta-analysis     
Submitted:  05 February 2018      Accepted:  20 May 2019      Published:  15 August 2020     
*Corresponding Author(s):  LIMAN YANG     E-mail:  limanlmy33@163.com

Cite this article: 

Liman Yang, Jing Jin, Juhong Liu. Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis. European Journal of Gynaecological Oncology, 2020, 41(4): 508-512.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.5189     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/508

[1] Yi-fan Luo, Li-xiang Ren, Ming-yan Jiang, Yang Chu. A systematic review and meta-analysis on the effects of metformin on survival outcomes and risk in women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 504-507.
[2] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[3] Fengmei Wang , Huachun Luo , Huihua Cheng, Huijuan Huang , Zhichao Fu. Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 591-597.
[4] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta. Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 629-633.
[5] Hikari Unno, Seiji Mabuchi, Isao Arai, Tomoko Wakasa, Seiichi Yamamasu. Development of lymphangiosarcoma after pelvic radiation therapy for uterine cervical cancer: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 326-331.
[6] B.-H. Zhang, L. Li, J. Ji, J. Guo, X.-L. Zhou, H. Xu, F. Cao, X.-H. Tong. Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 339-342.
[7] L. Xu, H. Cai, N. Zhu, Bo Zheng. Interleukin-22 derived from cervical cancer-associated fibroblasts accelerates senescence of normal fibroblasts and promotes expression of tumorigenesis-related factors in HeLa cells[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 192-199.
[8] Hong Yan, Chunhua Zhang, Tingting Liu, Jianzhong Liu. Mifepristone regulates the multidrug resistance via miR-758/MEPE of Hela cell lines[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 214-220.
[9] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[10] B. Bárány, R. Póka. Nutritional assessment among patients with cervical cancer and controls[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 23-29.
[11] D. Kim, Y. Ki, W. Kim, D. Park, D. Suh, K. Kim, J. Lee, H. Jeon, J. Nam. Positive pelvic lymph node on [18F]-FDG PET is a prognostic factor in early-stage high-risk cervical cancer treated by radical hysterectomy and adjuvant chemoradiotherapy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 42-47.
[12] H. Imafuku, Y. Ebina, K. Suzuki, S. Wakahashi, Y. Miyahara, K. Yoshida, H. Yamada. Definitive radiotherapy in elderly patients and patients with locally advanced cervical cancer with complications[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 60-64.
[13] Y. Murata, Y. Miyahara, K. Suzuki, S. Wakahashi, T. Sudo, S. Nagao, S. Yamaguchi, Y. Ebina, H. Yamada. Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 93-97.
[14] N. Habib, T. Dennis, G. Centini, L. Bresson, F. Narducci, E. Leblanc. Glassy cell carcinoma: is surgical treatment with preservation of the uterus a therapeutic option?[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 121-125.
[15] R. Tasaka, Y. Hashiguchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi. Secondary small cell carcinoma of the endometrium after concurrent chemoradiotherapy for cervical cancer: a rare case[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 142-144.
No Suggested Reading articles found!